Patents by Inventor Kathleen Lisaingo

Kathleen Lisaingo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220365072
    Abstract: Methods and devices are provided herein for identifying a cell population comprising an effector cell that exerts an extracellular effect. In one embodiment the method comprises retaining in a microreactor a cell population comprising one or more effector cells, wherein the contents of the microreactor further comprise a readout particle population comprising one or more readout particles, incubating the cell population and the readout particle population within the microreactor, assaying the cell population for the presence of the extracellular effect, wherein the readout particle population or subpopulation thereof provides a direct or indirect readout of the extracellular effect, and determining, based on the results of the assaying step, whether one or more effector cells within the cell population exerts the extracellular effect on the readout particle. If an extracellular effect is measured, the cell population is recovered for further analysis to determine the cell or cells responsible for the effect.
    Type: Application
    Filed: July 7, 2021
    Publication date: November 17, 2022
    Applicant: The University of British Columbia
    Inventors: Marketa RICICOVA, Kevin Albert HEYRIES, Hans ZAHN, Oleh PETRIV, Veronique LECAULT, Anupam Singhal, Daniel J. Da Costa, Carl L. G. Hansen, Brad NELSON, Julie NIELSEN, Kathleen Lisaingo
  • Publication number: 20220119522
    Abstract: In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.
    Type: Application
    Filed: August 16, 2021
    Publication date: April 21, 2022
    Applicant: Denali Therapeutics Inc.
    Inventors: Mark S. Dennis, Sherie Duncan, Kathleen Lisaingo, Kathryn M. Monroe, Joshua I. Park, Rachel Prorok, Ju Shi, Ankita Srivastava, Bettina Van Lengerich, Riley Walsh
  • Publication number: 20220073609
    Abstract: In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.
    Type: Application
    Filed: August 16, 2021
    Publication date: March 10, 2022
    Applicant: Denali Therapeutics Inc.
    Inventors: Mark S. Dennis, Sherie Duncan, Kathleen Lisaingo, Kathryn M. Monroe, Joshua I. Park, Rachel Prorok, Ju Shi, Ankita Srivastava, Bettina Van Lengerich, Riley Walsh
  • Publication number: 20210269792
    Abstract: The present invention relates to methods for isolating the sequences of an antibody that reacts with a disease related antigen, e.g., an autoantigen, without knowing the identity of the antigen (sequence or structural epitope) a priori. The methods can also be used to identify an antigen that mediates a disease state, e.g., an autoantigen implicated in an autoimmune disorder or a tumor response.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 2, 2021
    Inventors: Ester FALCONER, Carl Lars Genghis HANSEN, Veronique LECAULT, Kathleen LISAINGO, Kevin Albert HEYRIES
  • Publication number: 20200363401
    Abstract: Methods and devices are provided herein for identifying a cell population comprising an effector cell that exerts an extracellular effect. In one embodiment the method comprises retaining in a microreactor a cell population comprising one or more effector cells, wherein the contents of the microreactor further comprise a readout particle population comprising one or more readout particles, incubating the cell population and the readout particle population within the microreactor, assaying the cell population for the presence of the extracellular effect, wherein the readout particle population or subpopulation thereof provides a direct or indirect readout of the extracellular effect, and determining, based on the results of the assaying step, whether one or more effector cells within the cell population exerts the extracellular effect on the readout particle. If an extracellular effect is measured, the cell population is recovered for further analysis to determine the cell or cells responsible for the effect.
    Type: Application
    Filed: July 16, 2020
    Publication date: November 19, 2020
    Applicant: The University of British Columbia
    Inventors: Marketa RICICOVA, Kevin Albert HEYRIES, Hans ZAHN, Oleh PETRIV, Veronique LECAULT, Anupam Singhal, Daniel J. Da Costa, Carl L. G. Hansen, Brad NELSON, Julie NIELSEN, Kathleen Lisaingo
  • Patent number: 10725024
    Abstract: Methods and devices are provided herein for identifying a cell population comprising an effector cell that exerts an extracellular effect. In one embodiment the method comprises retaining in a microreactor a cell population comprising one or more effector cells, wherein the contents of the microreactor further comprise a readout particle population comprising one or more readout particles, incubating the cell population and the readout particle population within the microreactor, assaying the cell population for the presence of the extracellular effect, wherein the readout particle population or subpopulation thereof provides a direct or indirect readout of the extracellular effect, and determining, based on the results of the assaying step, whether one or more effector cells within the cell population exerts the extracellular effect on the readout particle. If an extracellular effect is measured, the cell population is recovered for further analysis to determine the cell or cells responsible for the effect.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: July 28, 2020
    Assignee: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Marketa Ricicova, Kevin Albert Heyries, Hans Zahn, Oleh Petriv, Veronique Lecault, Anupam Singhal, Daniel J. Da Costa, Carl L. G. Hansen, Brad Nelson, Julie Nielsen, Kathleen Lisaingo
  • Publication number: 20200156071
    Abstract: Methods and devices for identifying a cell population comprising an effector cell exhibiting an extracellular effect are provided. The method comprises retaining in a plurality of open chambers a plurality of cell populations, each optionally comprising one or more effector cells. The open chambers can each comprise a readout particle population, and the open chambers are present in a first component of a device comprising a first component and optionally a second component. The open chambers have an average aspect ratio of ?0.6 and the first component forms a reversible seal with the second component.
    Type: Application
    Filed: March 17, 2017
    Publication date: May 21, 2020
    Inventors: Carl Lars Genghis Hansen, Kathleen Lisaingo, Veronique Lecault
  • Publication number: 20200149031
    Abstract: The present invention relates to methods for isolating the sequences of an antibody that reacts with a disease related antigen, e.g., an autoantigen, without knowing the identity of the antigen (sequence or structural epitope) a priori. The methods can also be used to identify an antigen that mediates a disease state, e.g., an autoantigen implicated in an autoimmune disorder or a tumor response.
    Type: Application
    Filed: December 21, 2016
    Publication date: May 14, 2020
    Inventors: Ester FALCONER, Carl Lars Genghis HANSEN, Veronique LECAULT, Kathleen LISAINGO, Kevin Albert HEYRIES
  • Publication number: 20160252495
    Abstract: Methods and devices are provided herein for identifying a cell population comprising an effector cell that exerts an extracellular effect. In one embodiment the method comprises retaining in a microreactor a cell population comprising one or more effector cells, wherein the contents of the microreactor further comprise a readout particle population comprising one or more readout particles, incubating the cell population and the readout particle population within the microreactor, assaying the cell population for the presence of the extracellular effect, wherein the readout particle population or subpopulation thereof provides a direct or indirect readout of the extracellular effect, and determining, based on the results of the assaying step, whether one or more effector cells within the cell population exerts the extracellular effect on the readout particle. If an extracellular effect is measured, the cell population is recovered for further analysis to determine the cell or cells responsible for the effect.
    Type: Application
    Filed: March 28, 2014
    Publication date: September 1, 2016
    Inventors: Marketa Ricicova, Kevin Albert Heyries, Hans Zahn, Oleh Petriv, Veronique Lecault, Anupam Singhal, Daniel J. Da Costa, Carl L. G. Hansen, Brad Nelson, Julie Nielsen, Kathleen Lisaingo